BIOMARKERS FOR THE DETERMINATION OF SAMPLE ADEQUACY AND LUNG CANCER METASTASES

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250110132A1
SERIAL NO

18854884

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides methods to assess lymph node samples such as endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) samples to determine sample sufficiency and/or to detect metastasis in mediastinal lymph nodes using lymph node biomarkers. Also provided are devices and kits that can be used to perform the methods disclosed herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY HEALTH NETWORKTORONTO ON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FUJINO, Kosuke Kumamoto City, JP 5 26
ISHIWATA, Tsukasa Toronto, CA 4 1
KESHAVJEE, Shafique Toronto, CA 19 8
NAKAJIMA, Takahiro Chiba, JP 66 431
SAGE, Andrew Toronto, CA 8 17
YASUFUKU, Kazuhiro Toronto, CA 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation